Ameliorative effects of piroxicam on anthracene-induced lung toxicity in female Rattus norvegicus
References
- 1. Zhou, J., Xu., Y., Liu, J., Feng, L., Yu, J., Chen, D., 2024: Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol., 93, 102693. DOI: 10.1016/j. canep.2024.102693
- 2. Boyle, B. J., Shanks, T., Croom, S. M., Smith, R. J., Miller, L., Loaring, N., Heymans, C., 2000: The 2dF QSO redshift survey – I. The optical luminosity function of quasi-stellar objects. Mon. Not. the Royal Astronom. Soc., 317, 4, 1014–1022. DOI: 10.1046/j.1365-8711.2000.03730.x
- 3. Lyerly, A. D., 2010: Marking the fine line: ethics and the regulation of innovative technologies in human reproduction. Minnesota J. Law, Sci. & Tech., 11, 2, 685–712. https://scholarship.law.umn.edu/mjlst/vol11/iss2/10?utm_source=scholarship.law.umn.edu%2Fmjlst%2Fvol11%2Fiss2%2F10&utm_medium=PDF&utm_campaign=PDFCoverPages
- 4. Soerjomataram, I., Lortet-Tieulent, J., Parkin, D. M., Ferlay, J., Mathers, C., Forman, D., Bray, F., 2012: Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. The Lancet, 380, 9856, 1840–1850. DOI: 10.1016/s0140-6736(12)60919-2
- 5. Feely, R. A., Alin, S. R., Newton, J., Sabine, C. L., Warner, M., Devol, A., Krembs, C., Maloy, C., 2010: The combined effects of ocean acidification, mixing, and respiration on pH and carbonate saturation in an urbanized estuary. Estuar Coast & Shelf Sci., 88, 4, 442–449. DOI: 10.1016/j. ecss.2010.05.004
- 6. Ferlay, J., Randi, G., Bosetti, C., Levi, F., Negri, E., Boyle, P., La Vecchia, C., 2008: Declining mortality from bladder cancer in Europe. BJU Int., 101, 1, 11–19. DOI: 10.1111/j.1464-410x.2007.07239.x
- 7. Sylla, B. S., Wild, C. P., 2011: A million africans a year dying from cancer by 2030: What can cancer research and control offer to the continent? Int. J. Cancer, 130, 2, 245–250. DOI: 10.1002/ijc.26333
- 8. International Agency for Research on Cancer (IARC), 2020
- 9. Dix, D., Cohen, P., Flannery, J., 1980: On the role of aging in cancer incidence. J. Theor. Biol., 83, 1, 163–173. DOI: 10.1016/0022-5193(80)90377-x
- 10. Simmons, D. L., Botting, R. M., Hla, T., 2004: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev., 56, 3, 387–437. DOI: 10.1124/pr.56.3.3
- 11. Bayer, G., 2015: Matindale: The complete drug reference. 38th ed. Aust. Prescr., 38, 2, 59. DOI: 10.18773/austprescr.2015.023
- 12. Bhattacharya, S., Ghosh, R., Maiti, S., Khan, G. A., Sinha, A. K., 2013: The activation by glucose of liver membrane nitric oxide synthase in the synthesis and translocation of glucose transporter-4 in the production of insulin in the mice hepatocytes. PloS One, 8, 12, e81935. DOI: 10.1371/journal.pone.0081935
- 13. Saganuwan, S. A., Orinya, O. A. 2016: Toxico-neurological effects of piroxicam in monogastric animals. J. Exper. Neurosci., 10, 121–128. DOI: 10.4137/JEN.S40144
- 14. Saganuwan, S. A., 2016: Physicochemical and structure-activity properties of piroxicam—a mini review. Comp. Clin. Pathol., 25, 941–945. DOI: 10.1007/s00580-016-2284-3
- 15. Knapp, J. R., Freetly, H. C., Reis, B. L., Calvert, C. C., Baldwin, R. L., 1992: Effects of somatotropin and substrates on patterns of liver metabolism in lactating dairy cattle. J. Dairy Sci., 75, 4, 1025–1035. DOI: 10.3168/jds.s0022-0302(92)77846-1
- 16. Xin, B., Yokoyama, Y., Shigeto, T., Mizunuma, H., 2007: Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers. Pathol. Oncol. Res., 13, 4, 365–369. DOI: 10.1007/bf02940318
- 17. Earnet, D. L., Hixson, L. J., Alberts, D. S., 1992: Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem. Suppl., 50, S 16l, 156–166. DOI: 10.1002/jcb.240501330
- 18. Lindsey, P. A., Nyirenda, V. R., Barnes, J. I., Becker, M. S., McRobb, R., Tambling, C. J., 2014: Underperformance of African protected area networks and the case for new conservation models: insights from Zambia. PLoS One, 9, 5, e94109. DOI: 10.1371/journal.pone.0094109
- 19. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004: Tobacco smoke and involuntary smoking. Lyon (FR). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans., 83, 33–1187. https://www.ncbi.nlm.nih.gov/books/NBK316407/
- 20. Collin, G., Höke, H., Talbiersky, J., 2006: “Anthracene” in Ullmann’s Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim. https://doi.org/10.1002/14356007.a02_343.pub2
- 21. Verschueren, K., Marcoen, A., Schoefs, V., 1996: The internal working model of the self, attachment, and competence in five-year-olds. Child Dev., 67, 5, 2493–2511. PMID: 9022252.
- 22. Saini, R. K., Chouhan, R., Bagri, L. P., Bajpai, A. K., 2012: Strategies of targeting tumors and cancers. J. Cancer Res. Updates, 1, 129–152.
- 23. OECD 2015: OECD guidelines on corporate governance of state-owned enterprises. 2015 edition, OECD Publishing, Paris: 1–80. http://dx.doi.org/10.1787/9789264244160-en
- 24. Hodgson, E., 2004: A Textbook of Modern Toxicology 3rd ed., Wiley-InterScience, A. John Wiley & Sons, Inc., Publication, 557.
- 25. Kishi, S., Yokohira, M., Yamakawa, K., Saoo, K., Im-aida, K., 2024: Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice. Oncol. Lett., 8, 6, 2379–2386. DOI: 10.3892/ol.2014.2559
- 26. Oluchi, O. M., Chukwuebuka, N. H., Orbunde, D. K., Daniel, A. W., Aondohemba, U. V., Ieren, I. I., Bosha, J. A., Saganuwan, S. A., Azubuike, O. P., 2024: Benz[a]anthracene-induced pulmonary toxicity in Rattus norvegicus. J. Toxicity Envir. Health Sci., 16, 1, 1–12. DOI: 10.5897/JTEHS2023.0517
- 27. Saganuwan, S. A., Onyeyili, P. A., 2016: The paradox of human equivalent dose formula: a canonical case study of Abrus precatorius aqueous leaf extract in monogastric animals. Mac. Vet. Rev., 39, 1, 23–32. https://macvetrev.mk/LoadAbstract?DOI=10.1515_macvetrev_2015_0061
- 28. Thermo Fisher Scientific, 2024: Carboplatin In: Safety Data Sheet, Health, Safety and Environment Department, 1–8.
- 29. Davis, R. K., Stevenson, G. T., Busch, K. A., 1956: Tumor incidence in normal Sprague-Dawley female rats. Cancer Res., 16, 3, 194–197. PMID: 13304860.
- 30. Nagabhushanam, M. V., Sudha, R. A., 2010: Evaluation of phamacokinetic parameters of solid dispersions of piroxicam, 333–343. Inkollu: DCRM pharmacy College, Department of Pharmaceutics. [Google Scholar].
- 31. Akogwu, E., I., Saganuwan, S. A., Onyeyili, P. A., 2017: Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats. Cog. Food & Agric., 3, 1, 1–8. DOI: 10.1080/23311932.2017.1294444
- 32. Barros, A. C. S. D, Muranaka, E. N. K., Mori, L. J., Pelizon, C. H. T., Iriya, K., Giocondo, G., Pinotti, J. A. 2004: Induction of experimental mammary carcinogenesis in rats with 7, 12-methyl-benz(a)anthracene. Rev. Hosp. Clin., 59, 5, 257–261. DOI: 10.1590/s0041-87812004000500006
- 33. Saganuwan, S. A., 2021: Modified formulas for calculation of encephalization: quotient in dogs. BMC Res. Notes, 14, 1, 223. DOI: 10.1186/s13104-021-05638-0
- 34. Saganuwan, S. A., 2018: Mathematical determination of some oncological parameters and their therapeutic applications in dogs. Comp. Clin. Pathol., 28, 1025–1030. DOI: 10.1007/s00580-018-2874-3
- 35. Saganuwan, S. A., 2012: Principles of Pharmacological Calculations, 1st ed., Ahmadu Bello University Press.
- 36. Daniel, W. W., Cross, C. L., 2010: Biostatistics: Basic Concept and Methodology for Health Sciences, 9th edn., Wiley, New Delhi, 777.
- 37. Abatan, M. O., Lattef, I., Taiwo, V., O., 2006: Toxic effects of non-steroidal anti-inflammatory agents in rats. Afr. J. Biomed. Res., 9, 219–223. DOI: 10.4314/ajbr.v9i3.48909
- 38. Stark, A. A., 1980: Mutagenicity and carcinogenicity of mycotoxins: DNA binding as a possible mode of action. Ann. Rev. Microbiol., 34, 235–262. DOI: 10.1146/annurev. mi.34.100180.001315
- 39. Gamrat-Zmuda, A., Minasyan, M., Wysocki, P. J., Hubalewska-Dydejezyk, A., Gilis-Januszeuskal, A., 2025: Ectopic cushing’s syndrome in advanced small-cell lung cancer (SCLC): clinical challenges and therapeutic insights. Cancer (Basel), 17, 10, 1611. https://doi.org/10.3390/cancers17101611
- 40. Saganuwan, S. A., 2023: Ameliorative effects of piroxicam on perchloric acid-induced thyroid gland hormones disruption in male rats. J. King Saud Univ.-Sci., 35, 2, 102661. DOI: 10.1016/j.jksus.2023.102661
- 41. Schmidt-Nielsen, K., 1964: Desert animals: physiological problems of heat and water. Claredon press, Oxford.
- 42. Alamdari, S. G., Mohammadzadeh, R., Amini, M., Najafi, S., Baradaran, B., Mahdavi, S. Z. B., Yari, A., Mokhtarzadeh, A. A., 2025: Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression. Sci. Rep., 15, 7971. DOI: 10.1038/s41598-025-87649-6
- 43. Samani, A., Bennett, R., Eremeishvili, K., Kalofonou, F., Whear, S., Montes, A., et al., 2022: Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers. ESMO Open, 7, 2, 100401. DOI: 10.1016/j.esmoop.2022.100401
- 44. Knapp, D. W., Chan, T. C., Kuczek, T., Reagan, W. J., Park, B., 1995: Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. Am. J. Vet. Res., 56, 6, 801–5. PMID: 7653891.
- 45. Malfassi, L., Fidanzio, F., Sala, M., Marcarini, S., Mazza, G., Carrara, N., et al., 2021: A combined protocol with piroxicam, chemotherapy, and whole pelvic irradiation with simultaneous boost volumetric modulated arc radiotherapy for muscle-invasive canine urinary transitional cell carcinoma: First clinical experience. J. Vet. Med. Sci., 83, 4, 695–704. DOI: 10.1292/jvms.19-0662
- 46. Chang, M. T., Penson, A., Desai, N. B., Socci, N. D., Shen, R., Seshan, V. E., et al., 2018: Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis. Clin. Cancer Res., 24, 8, 1965–1973. DOI: 10.1158/1078-0432.CCR-17-2655
- 47. Pollard, M., Luckert, P. H., Schmidt, M. A., 1983: The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat. Cancer Lett., 21, 1, 57–61. DOI: 10.1016/0304-3835(83)90082-4
- 48. Menter, D. G., DuBois, R. N., 2012: Prostaglandins in cancer cell adhesion, migration, and invasion. Int. J. Cell Biol., 723419. DOI: 10.1155/2012/723419
- 49. Lazer, E. S., Miao, C. K., Cywin, C. L., Sorcek, R., Wong, H.-C., Meng, Z., et al., 1997: Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity. J. Med. Chem., 40, 6, 980–989. DOI: 10.1021/jm9607010
- 50. Saganuwan, S. A., Egworrow, O. E., Ode, A. J., 2023: Effects of diminazene aceturate on flip-flop plasma pharmacokinetics of piroxicam in dogs. J. King Saud Univ.-Sci., 35, 16, 102914. DOI: 10.1016/j.jksus.2023.102914
- 51. Soni, M. G, 2014: Benz[a]anthracene In: Gray, J. P. and Hall, G. J. (eds) of Toxicology, 2nd ed., 413–414.
- 52. Kishi, K., Homma, S., Kurosaki, A., Motoi, N., Kohno, T., Nakata, K., Yoshimura, K., 2004: Small lung tumors with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung cancer, 44, 1, 43–51. DOI: 10.1016/j.lungcan.2003.09.024
- 53. Hong, J. H., Park, S., Kim, H., Goo, J. M., Park, I. K., Kang, C. H., et al., 2021: Volume and mass doubling time of time lung adenocarcinoma according to WHO histologic classification. Korean J. Radiol., 22, 3, 464–-475. DOI: 10.3348/kjr.2020.0592
- 54. De Sousa, G. F., Wlodarczyk, S. R., Monteiro, G., 2014: Carboplatin: molecular mechanisms of action associated with chemoresistance. Braz. J. Pharm. Sci., 50, 4, 1–9. DOI: 10.1590/S1984-82502014000400004
- 55. Recnik, L.-M., Cantelli, C., Fersing, C., Gongora, C., Pouget, J.-P., Lisowski, V., 2020: Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems. Bioorg. Med. Chem. Lett., 30, 22, 127527. DOI: 10.1016/j.bmcl.2020.127527
- 56. Vermorken, J. B., ten Bokkel Huinink, W. W., Eisenhauer, E. A., Favalli, G., Belpomme, D., Conte, P. F., Kaye, S. B., 1993: Advanced ovarian cancer. Carboplatin versus cisplatin. Ann Oncol., 4, 4, 41–48. PMID: 8312200.
- 57. Miyano, K., Shiraishi, S., Minami, K., Sudo, Y., Suzuki, M. M., Yokoyama, T., et al., 2019: Carboplatin enhances the activity of human transient receptor potential ankyrin 1 through the cyclic AMP-protein kinase A-A-kinase anchoring protein (AKAP) pathways. Int. J. Mol. Sci., 20, 13, 3271. DOI: 10.3390/ijms20133271
- 58. Millen, G. C., Lawford, A., Duncan, C., Jenkinson, H., Veal, G. J., Barnett, S., 2024: Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom. Br. J. Cancer, 131, 3, 491–497. DOI: 10.1038/s41416-024-02728-1
- 59. Mo, J., Eggers, P. K., Chen, X., Ahamed, M. R. H., Becker, T., Lim, L. Y., Raston, C. L., 2015: Shear induced carboplatin binding within the cavity of a phospholipid mimic for increased anticancer efficacy. Sci. Rep., 5, 10414, 1–9. DOI: 10.1038/srep10414
- 60. Faulkner, D., Meldrum, C., 2012: Tumour markers. Aust. Prescr., 35, 4, 125–128. DOI: 10.18773/austprescr.2012.052
- 61. Kumar, K., Jain, P., Sinha, A., Singh, K. K., Sharma, H. P., 2014: Clinical significance of tumor markers. Am. J. Phytomed. Clin. Ther., 2, 8, 1005–1015.
- 62. Flectcher, R. H., 1986: Carcinoembryonic antigen. Ann. Intern. Med., 104, 1, 66–73. DOI: 10.7326/0003-4819-104-1-66
- 63. Hansen, M., 1991: Serum tumour markers in lung cancer. Scand. J. Clin. Lab. Invest., 51, 206, 93–101.
- 64. Ferrigno, D., Buccheri, G., 1995: Clinical applications of serum markers for lung cancer. Respir. Med., 89, 9, 587–597. DOI: 10.1016/0954-6111(95)90225-2
- 65. Tiep, B., Carter, R., Zachariah, F., Williams, A. C., Horak, D., Barnet, M., Dunham, R., 2013: Oxygen for the end-of-life lung cancer care: managing dyspnea and hypoxemia. Expert Rev. Respir. Med., 7, 5, 479–490. DOI: 10.1586/17476348.2013.816565
- 66. Igarashi, H., Fukushi, M., Nago, N., 2020: Oxygen use and survival in patients with advanced cancer and low oxygen saturation in home care: a preliminary retrospective cohort study. BMC Palliat. Care, 19, 3. DOI: 10.1186/s12904-019-0511-9
- 67. Jones, L. W., Watson, D., Herndon, J. E., Eves, N. D., Haithcock, B. E., Loewen, G., Kohman, L., 2010: Peak Oxygen consumption and long-term all-cause mortality in non-small cell lung cancer. Cancer, 116, 20, 4825–4832. DOI: 10.1002/cncr.25396
- 68. Licker, M., Schnyder, J.-M., Frey, J.-G., Diaper, J., Cartier, V., Inan, C., et al., 2011: Impact of aerobic exercise capacity and procedure-related factors in lung cancer surgery. Eur. Respir. J., 37, 5, 1189–1198. DOI: 10.1183/09031936.00069910
- 69. Franklin, J., Serra-Diaz, J. M., Syphard, A. D., Regan, H. M., 2016: Global change and terrestrial plant community dynamics. Proc. Natl. Acad. Sci. USA, 113, 14, 3725–3734. DOI: 10.1073/pnas.1519911113
- 70. U.S. Environmental Protection Agency guidelines for carcinogen risk assessment, 1986.
Language: English
Page range: 49 - 63
Submitted on: Jun 12, 2025
Accepted on: Sep 25, 2025
Published on: Dec 23, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2025 Anthony Maryjane Uzoamaka, Saganuwan Alhaji Saganuwan, Ahur Maskavem Victor, Titilayo Akande, published by The University of Veterinary Medicine and Pharmacy in Košice
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.